Microlig AD 20mg/ml/0.005mg/ml Injection
Marketer
Favnox Pharmaceuticals Private Limited
Salt Composition
Lidocaine (20mg/ml) + Adrenaline (0.005mg/ml)
Overview Microlig AD 20mg/ml/0.005mg/ml Injection
Microlig AD Injection (20mg/ml and 0.005mg/ml) is a combined anesthetic agent for localized pain relief. It acts by interrupting nerve transmission of pain signals to the brain, reducing pain sensation. Administration must be by injection, under strict medical supervision; self-injection is strictly prohibited. Dosage and treatment length are solely determined by your physician. Adhere precisely to your doctor's instructions. Common, usually mild, side effects include pale skin, burning, stinging, and itching. However, persistent or bothersome symptoms should be reported to your doctor. Prior to treatment, disclose any pre-existing liver or kidney conditions, pregnancy, or breastfeeding. It's crucial to inform your healthcare provider of all other medications you're using, as interactions are possible.
Uses of Microlig AD 20mg/ml/0.005mg/ml Injection
Regional numbing achieved through localized anesthetic.
Major Benefits of Microlig AD 20mg/ml/0.005mg/ml Injection:
Administering this medication will be done by your physician or their qualified staff; self-medication is strictly prohibited.
Common Side effects of Microlig AD 20mg/ml/0.005mg/ml Injection:
- Pale skin
- Burning sensation
- Stinging sensation
- Erythema (skin redness)
- Itching
- Pain
- Petechiae (red or purple spot caused by bleeding into the skin)
How to use Microlig AD 20mg/ml/0.005mg/ml Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Microlig AD 20mg/ml/0.005mg/ml Injection works:
Lidocaine and Epinephrine Injection (Microlig AD 20mg/ml/0.005mg/ml) combines a local anesthetic with a vasoconstrictor to provide effective localized pain relief. Lidocaine blocks nerve signals, preventing pain sensations from reaching the brain. Epinephrine's vasoconstricting action reduces blood flow, slowing Lidocaine's absorption and extending its analgesic effect. This synergistic action ensures prolonged numbness, facilitating comfortable performance of medical procedures.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using alcohol concurrently with Microlig AD 20mg/ml/0.005mg/ml Injection. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Microlig AD 20mg/ml/0.005mg/ml Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Microlig AD 20mg/ml/0.005mg/ml Injection while breastfeeding is likely inadvisable. Scant clinical evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Administering Microlig AD 20mg/ml/0.005mg/ml Injection typically has no impact on driving capabilities.
KidneyCAUTION
Administering Microlig AD Injection (20mg/ml/0.005mg/ml) requires careful consideration in individuals with significant renal impairment. Dosage modification of Microlig AD Injection (20mg/ml/0.005mg/ml) may be necessary. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Microlig AD 20mg/ml/0.005mg/ml Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Microlig AD 20mg/ml/0.005mg/ml Injection :
NA
Facts to Know About Microlig AD 20mg/ml/0.005mg/ml Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
3,018 People bought this recently